Zhejiang Orient Gene Biotech Co (SHSE:688298) Beginning Cash Position: ¥891 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688298 Zhejiang Orient Gene Biotech Co Ltd SHSE:688298
56 GF Score
Price ¥17.94
GF Value ¥31.10
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Zhejiang Orient Gene Biotech Co Beginning Cash Position?

Zhejiang Orient Gene Biotech Co SHSE:688298 -1.91% 56 Beginning Cash Position is ¥891 Mil as of Jun. 2026. GuruFocus rates SHSE:688298 with a GF Score™ of 56/100 and a GF Value™ of ¥31.10 (Possible Value Trap). The stock has 2 warning signs investors should review.

Zhejiang Orient Gene Biotech Co's Beginning Cash Position for the quarter that ended in Jun. 2026 was ¥891 Mil.

Zhejiang Orient Gene Biotech Co's quarterly Beginning Cash Position increased from Dec. 2025 (¥818 Mil) to Mar. 2026 (¥1,636 Mil) but then declined from Mar. 2026 (¥1,636 Mil) to Jun. 2026 (¥891 Mil).

Zhejiang Orient Gene Biotech Co's annual Beginning Cash Position declined from Dec. 2023 (¥6,557 Mil) to Dec. 2024 (¥2,929 Mil) and declined from Dec. 2024 (¥2,929 Mil) to Dec. 2025 (¥1,510 Mil).

Zhejiang Orient Gene Biotech Co Beginning Cash Position Related Terms

Zhejiang Orient Gene Biotech Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Zhejiang Orient Gene Biotech Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Orient Gene Biotech Co Beginning Cash Position Chart

Zhejiang Orient Gene Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,800.34 6,097.94 6,556.56 2,928.60 1,510.28

Zhejiang Orient Gene Biotech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,038.63 1,443.68 818.31 1,635.69 891.18
SHSE:688298
56GF Score
Zhejiang Orient Gene Biotech Co Ltd SHSE:688298
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Orient Gene Biotech Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ¥891 Mil mean?
Zhejiang Orient Gene Biotech Co (SHSE:688298) has a Beginning Cash Position of ¥891 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Zhejiang Orient Gene Biotech Co and its competitors.
Is Zhejiang Orient Gene Biotech Co's Beginning Cash Position too high?
Zhejiang Orient Gene Biotech Co's current Beginning Cash Position is ¥891 Mil. Overall, Zhejiang Orient Gene Biotech Co has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Orient Gene Biotech Co's Beginning Cash Position compare to ABT and SYK?
Zhejiang Orient Gene Biotech Co's Beginning Cash Position of ¥891 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Zhejiang Orient Gene Biotech Co and its competitors. Zhejiang Orient Gene Biotech Co's current Beginning Cash Position is ¥891 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Orient Gene Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Orient Gene Biotech Co (SHSE:688298) is currently considered Possible Value Trap. The stock's GF Value™ is ¥31.10, compared to a current price of ¥17.94 — trading 42.3% below its estimated fair value. The current Beginning Cash Position is ¥891 Mil. Zhejiang Orient Gene Biotech Co's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Zhejiang Orient Gene Biotech Co (SHSE:688298), the current Beginning Cash Position is ¥891 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Orient Gene Biotech Co (SHSE:688298) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Orient Gene Biotech Co stock appears to be undervalued. The current stock price of ¥17.94 is trading 42.3% below its estimated GF Value™ of ¥31.10. GuruFocus considers Zhejiang Orient Gene Biotech Co to be Possible Value Trap.

Key valuation signals for SHSE:688298:

  • Beginning Cash Position: ¥891 Mil
  • GF Value™: ¥31.10 vs. price of ¥17.94 (42.3% below fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688298 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Orient Gene Biotech Co Business Description

Address 3787 East Section of Yangguang Avenue, Dipu Street, Anji County, Zhejiang Province, Huzhou, CHN, 313300
Zhejiang Orient Gene Biotech Co Ltd is engaged in production, research, development and sale of vitro diagnostic products. The company's products include Genetic diagnosis, Colloidal gold rapid diagnostic tests, Dry chemical strips (urinalysis), Bio-liquid diagnostic kits, Clinical test instruments, POCT time-resolved Fluor immunoassay Test kit (TRFI), and Raw materials.
56GF Score

Get the complete analysis for SHSE:688298

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.94
Price
¥31.10
GF Value